AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ROSIGLITAZONE
9 registrations across 2 African markets— 9 active
Markets with ROSIGLITAZONE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AVANDIA COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| ROSIX comprimé / 2 mg | 🇸🇳Senegal | GENPHARMA | active | — |
| AVANDIA COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| ROSIX comprimé / 8 mg | 🇸🇳Senegal | GENPHARMA | active | — |
| ROSIX comprimé / 4 mg | 🇸🇳Senegal | GENPHARMA | active | — |
| ROSIX comprimé / 4 mg | 🇸🇳Senegal | GENPHARMA | active | — |
| AVANDIA COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| ROSIX comprimé / 8 mg | 🇸🇳Senegal | GENPHARMA | active | — |
| AVANDIA COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
ROSIGLITAZONE in Africa — Regulatory Overview
ROSIGLITAZONE is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Morocco. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.